ARTICLE | Company News
MorphoSys, Daiichi Sankyo deal
May 25, 2009 7:00 AM UTC
Daiichi Sankyo exercised its option to add two new undisclosed cancer targets to a 2006 deal to use MorphoSys' HuCAL technology to generate antibodies against targets from the pharma. Daiichi Sankyo a...